Celltrion
068270.KS
£93.03
Share price
-2.26%
Change (1 day)
-17.08%
Change (1 year)
Categories
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.
Celltrion (068270.KS) - Total liabilities
Total liabilities on the balance sheet as of December 2024 : £1.82 Billion
According to Celltrion 's latest financial reports the company's total liabilities are £1.82 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Celltrion - Total liabilities on balance sheet (from 2007 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | £1.88 B | 9.86% |
| 2023-12-31 | £1.71 B | 62.02% |
| 2022-12-31 | £1.06 B | 4.88% |
| 2021-12-31 | £1.01 B | -5.99% |
| 2020-12-31 | £1.07 B | 65.26% |
| 2019-12-31 | £0.65 B | 1.57% |
| 2018-12-31 | £0.64 B | 4.47% |
| 2017-12-31 | £0.61 B | 10.84% |
| 2016-12-31 | £0.55 B | 2.71% |
| 2015-12-31 | £0.53 B | -5.74% |
| 2014-12-31 | £0.57 B | 11.5% |
| 2013-12-31 | £0.51 B | 25.96% |
| 2012-12-31 | £0.40 B | 44.42% |
| 2011-12-31 | £0.28 B | 30.54% |
| 2010-12-31 | £0.21 B | 47% |
| 2009-12-31 | £0.14 B | -4.37% |
| 2008-12-31 | £0.15 B | 710.36% |
| 2007-12-31 | £18.94 M |